Scientific Publications by FDA Staff
AIDS 2011 Jun 1;25(9):1229-32
Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.
Althoff KN, Eichelberger M, Gange SJ, Sharp GB, Gao J, Glesby MJ, Young M, Greenblatt RM, French AL, Villacres MC, Minkoff H
The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected April 1 - September 30, 2009 and the prior two years from Women's Interagency HIV Study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 count ¿350 cells/mm compared with HIV-uninfected women. Due to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.
|Category: Journal Article, Letter|
|PubMed ID: #21505313||DOI: 10.1097/QAD.0b013e3283471cf2|
|Includes FDA Authors from Scientific Area(s): Biologics|
|Entry Created: 2011-10-03||Entry Last Modified: 2012-08-29|